← New England News
Health

🩺 NH man lived 271 days with genetically edited pig kidneyLancet reports first transition from pig kidney to human transplant 👇

A New Hampshire man lived dialysis-free for 271 days with a genetically engineered pig kidney before later receiving a human kidney, according to a peer-reviewed report published in The Lancet. Tim Andrews of Concord, who was 66 when the experimental transplant was performed, received the pig kidney at Massachusetts General Hospital in January 2025 after developing end-stage kidney disease.

The kidney came from a genetically modified pig developed by eGenesis, a Cambridge, Massachusetts biotechnology company working on organs designed to reduce the risk of rejection when transplanted into humans. Andrews was able to remain off dialysis for nearly nine months while doctors closely monitored the organ and adjusted medications intended to suppress his immune response.

The pig kidney was removed in October 2025 after its function deteriorated amid microvascular injury and inflammation. Andrews returned to dialysis following removal of the xenograft. In January 2026, approximately three months later, he received a kidney from a deceased human donor. Researchers described the case as the first reported transition from a porcine kidney xenograft to a human kidney transplant, demonstrating that an animal organ could potentially serve as a temporary bridge for some patients awaiting a conventional transplant.

The case also illustrates significant challenges that remain before xenotransplantation could become routine. Andrews experienced episodes of rejection and ultimately lost the pig kidney despite extensive genetic modifications and immunosuppressive treatment. Researchers are continuing to study genetically engineered pig kidneys in patients with kidney failure as they evaluate their durability, immune complications and potential role in addressing the shortage of human donor organs.

Community Discussion
💬 Could genetically engineered animal organs eventually become a practical bridge for patients waiting years for human donor kidneys?